<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="10558" OLDID="16079" TOPICS="NO">
<DATE>27-MAR-1987 12:57:35.34   F</DATE>
<UNKNOWN>   f1736 reute</UNKNOWN>
<TOPICS/>
<PLACES><D>sweden</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
d f BC-PHARMACIA-UNIT-SIGNS   03-27 0099</UNKNOWN>
<TEXT> 
<TITLE>PHARMACIA UNIT SIGNS NICOTINE TECHNOLOGY LICENCE</TITLE>
<DATELINE>    STOCKHOLM, March 27 - </DATELINE><BODY>Sweden's &lt;AB Leo&gt;, manufacturer of
the anti-smoking chewing gum Nicorette, said it had signed a
letter of intent to study the nicotine technology of &lt;Advanced
Tobacco Products Inc&gt; (ATPI) of San Antonio, Texas.
    Leo, a subsidiary of Pharmacia AB &lt;PHAB ST&gt;, said the
agreement gives it the option of acquiring worldwide licences
and rights to ATPI at the end of its period of study.
    No cash details of the deal were given and Leo said no
further details would be given until a definite agreement had
been signed.
 Reuter
 </BODY></TEXT>
</REUTERS>